Wealth Management by

Egyptian drugmaker exploring possible sale

May 22, 2014 1:21 am

Egyptian drugmakers, Amoun Pharmaceutical Co has hired Jefferies Group to explore a potential sale, Bloomberg has reported. While a sale of Amoun is being explored, a deal is yet to be reached, Amoun CEO, Mohamed Roushdy, told the news service. The company’s owners include emerging market-focused private equity arms of Capital Group Inc., New York-based Concord International Investments, and the Rohatyn Group, which bought Citigroup Inc.’s buyout business last year.